Michael A. Zasloff - Mar 5, 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role: Director
Signature: /s/ Eva Wen, by power of attorney
Stock symbol: AMPH
Transactions as of: Mar 5, 2024
Transactions value $: -$589,724
Form type: 4
Date filed: 3/6/2024, 05:57 PM
Previous filing: Aug 16, 2023
Next filing: Jun 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMPH	Common Stock	Sale	-$442K	-9.39K	-27.76%	$47.06	24.4K	Mar 5, 2024	Direct	F1
transaction	AMPH	Common Stock	Sale	-$148K	-3.11K	-12.73%	$47.53	21.3K	Mar 5, 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.435 to $47.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.435 to $47.68, inclusive.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.435 to $47.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.435 to $47.68, inclusive.